Jan 26, 2022 / 08:00AM GMT
Vivienne Parry - BBC Television - Media
Welcome to Edison Open House Global Healthcare 2022. In this session, we're highlighting the work of Kazia, an Australian oncology biotech focused on solid tumors. To tell me more is CEO, James Garner. Hello, James.
James Garner - Kazia Therapeutics Ltd. - CEO & Executive Director
Hello, Vivienne. Great to be with you again.
Questions and Answers:
Vivienne Parry - BBC Television - MediaSo first of all, tell me a bit more about the business model of Kazia, which is an unusual one.
James Garner - Kazia Therapeutics Ltd. - CEO & Executive Director
Kazia doesn't invent drugs. We look for drugs that really excite us, but which exist in other companies and which aren't strategic for those companies, they don't fit with the business of the company they're currently in. We look to bring them into Kazia, we take them through clinical trials and we bring them forward to patients.
And the two drugs in our pipeline
Trustpilot
